PFM
TWST icon

Privium Fund Management’s Twist Bioscience TWST Stock Holding History

Privium Fund Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,950
Closed -$314K – 86
2024
Q3 		$314K Buy
6,950
+2,420
+53% +$115K 0.08% 63
2024
Q2 		$214K Buy
+4,530
New +$185K 0.05% 87

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Privium Fund Management's TWST Position: Q4 2024 in Review

Privium Fund Management sold out of Twist Bioscience (TWST) in Q4 2024, closing a stake of 6,950 shares — an estimated $314K sold.

Privium Fund Management first reported a position in TWST in Q2 2024 and held it in 2 quarters. The position peaked at $314K in Q3 2024. 247 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

  • Privium Fund Management reported no remaining Twist Bioscience position as of Q4 2024 after selling out during the quarter.
  • Privium Fund Management sold 6,950 Twist Bioscience shares in Q4 2024, an estimated $314K.
  • Privium Fund Management first reported a position in Twist Bioscience in Q2 2024 and held it in 2 quarters.
  • Privium Fund Management's Twist Bioscience position peaked at $314K in Q3 2024.
  • 247 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Privium Fund Management's 13F filing for Q4 2024, filed 11 Feb 2025.